19.04
-0.07 (-0.37%)
| Previous Close | 19.11 |
| Open | 19.09 |
| Volume | 893,356 |
| Avg. Volume (3M) | 1,340,614 |
| Market Cap | 939,927,744 |
| Price / Earnings (Forward) | 50.25 |
| Price / Sales | 4.10 |
| Price / Book | 2.67 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | -25.46% |
| Operating Margin (TTM) | -81.43% |
| Diluted EPS (TTM) | -1.44 |
| Quarterly Revenue Growth (YOY) | -44.90% |
| Quarterly Earnings Growth (YOY) | 107.20% |
| Total Debt/Equity (MRQ) | 10.48% |
| Current Ratio (MRQ) | 4.78 |
| Operating Cash Flow (TTM) | -11.69 M |
| Levered Free Cash Flow (TTM) | 10.73 M |
| Return on Assets (TTM) | -5.90% |
| Return on Equity (TTM) | -19.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Bearish | |
| Stock | STAAR Surgical Company | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | -2.5 |
| Average | -1.75 |
|
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 0.64% |
| % Held by Institutions | 109.43% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Broadwood Capital Inc | 30 Sep 2025 | 13,519,491 |
| Yunqi Capital Ltd | 30 Sep 2025 | 2,500,061 |
| Sand Grove Capital Management Llp | 30 Sep 2025 | 829,123 |
| American Capital Management Inc | 30 Sep 2025 | 743,424 |
| Defender Capital, Llc. | 31 Dec 2025 | 668,222 |
| Water Island Capital Llc | 30 Sep 2025 | 658,317 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 30.75 (Wells Fargo, 61.50%) | Hold |
| Median | 22.00 (15.55%) | |
| Low | 21.50 (Jefferies, 12.92%) | Buy |
| Average | 24.75 (29.99%) | |
| Total | 1 Buy, 2 Hold | |
| Avg. Price @ Call | 21.33 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 28 Jan 2026 | 21.50 (12.92%) | Buy | 19.04 |
| Canaccord Genuity | 16 Jan 2026 | 22.00 (15.55%) | Hold | 20.97 |
| 10 Dec 2025 | 30.75 (61.50%) | Hold | 23.99 | |
| Wells Fargo | 10 Dec 2025 | 30.75 (61.50%) | Hold | 23.99 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |